Mutation clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Patients With HPDL Mutations
open to all eligible people
This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations
at UCSD
Our lead scientists for Mutation research studies include Joseph Gleeson.
Last updated: